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Abstract Intracellular heat shock protein (Hsp) 27 is a
potent anti-apoptotic factor that, among other activities,
prevents the binding of membrane receptor Fas to its ligand
FasL. However, the potential role of extracellular Hsp27 and
possibilities to control it have not been clarified. Moreover,
there are no data on relations between Hsp27, sFas/sFasL
system, matrix metalloproteinases (MMPs) and their tissue
inhibitors (TIMPs) in patients with chronic kidney disease
(CKD)—neither children nor adults. The aim of this study
was to evaluate serum concentrations of Hsp27 and their
potential regulators (sFas, sFasL, MMP-7, TIMP-1) in chil-
dren with CKD and on chronic dialysis. Twenty-six CKD
children stage 5 still on conservative treatment, 19 patients
on hemodialysis (HD), 22 children on automated peritoneal
dialysis (APD), and 30 controls were examined. Serum
concentrations of Hsp27, sFas, sFasL, MMP-7, and TIMP-
1 were assessed by ELISA. Median values of Hsp27 were
significantly elevated in all dialyzed patients vs. those in
pre-dialysis period and vs. controls, the highest values being
observed in subjects on HD. Regression analysis revealed
that MMP-7, TIMP-1, sFas, and sFasL were the best pre-
dictors of Hsp27 concentrations in dialyzed patients. Chil-
dren with CKD are prone to Hsp27 dysfunction, aggravated
by the dialysis commencement, and more pronounced in
patients on hemodialysis. Correlations between Hsp27 and
examined parameters suggest the potential role for Hsp27 as
a marker of cell damage in the pediatric population on
chronic dialysis.
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Introduction
Chronic inflammation, immune system activation, and en-
hanced apoptosis are characteristic features of chronic kid-
ney disease (CKD), additionally aggravated by the dialysis
procedure and the membrane type (Andreoli et al. 2007;
Soriano et al. 2005). Various heat shock proteins take part in
the abovementioned processes. Among them, intracellular
Hsp27 seems to play a crucial role in apoptosis regulation,
controlling both intrinsic and extrinsic pathways of
programmed cell death (Concannon et al. 2003; Sanchez-
Nino et al. 2012). The extrinsic one is initiated by the
binding of membrane receptor Fas to its ligand FasL. This
action can be inhibited by Hsp27, blocking the Daxx trans-
location to the membrane and its interaction with Fas
(Nagata and Goldstein 1995; Charette et al. 2000). Hsp27
can also regulate negatively apoptosis by both upstream and
downstream inhibition of cytochrome c release (Concannon
et al. 2003). However, there are no data on the character of
Hsp27/Fas/FasL intracellular interactions in the course of
chronic kidney disease or under dialysis conditions.
Recent investigation has focused on the soluble forms of
abovementioned parameters, sHsp27, sFas, FasL, and their
potential role in cell damage. Extracellular Hsp are mainly
considered the markers of damage, released under patholog-
ical conditions by the injured or necrotic cells, and “danger
signals,” directing the innate immune system towards Hsp
recognition by antigen presenting cells (APC) (Calderwood
et al. 2007; Joly et al. 2010). The subsequent production of
pro-inflammatory cytokines by APC and activation of nu-
clear factor (NF)-κB facilitates adaptive immune response
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and antigen presentation to cytotoxic T cells (Srivastava
2002). However, the significance of this sequence has been
questioned recently by van Eden et al. (van Eden et al.
2012). The authors suggested that Hsp should not be treated
solely as damage-associated molecular patterns (DAMPs),
responsible mainly for pro-inflammatory stimulation of the
immune system, but also as factors able to suppress immune
response and favor the process of tissue restoration after
damage. Henderson and Pockley went even further, hypoth-
esizing that extracellular Hsp may play actively as autocrine,
paracrine, or endocrine signals, either cardioprotective (like
Hsp27) or cardiopathologic (Henderson and Pockley 2012).
Such interpretation surely throws a new light on the role of
Hsp in CKD-related complications.
Uremic toxicity increases Fas and FasL expression on
cells, thus evoking changes in sFas and sFasL concentra-
tions (Jaber et al. 2001). Apart from their anti-apoptotic
(sFas) and pro-apoptotic (sFasL) activity, they are regarded
as markers of inflammation and endothelial dysfunction,
and therefore classified as hallmarks of atherosclerosis (El-
Agroudy and El-Baz 2010; Dalboni et al. 2003). However,
there are no data on potential links between extracellular
Hsp27 and sFas/sFasL system in the course of CKD.
Other inflammation markers, like hsCRP or IL-4, have
not been tested for their potential relations with Hsp27
either. E-selectin, adhesion molecule expressed on endothe-
lial cells, constitutes an ideal marker of their activation,
which is followed by sE-selectin cleavage, pointing at en-
dothelial damage. However, there are no data on connec-
tions between this molecule in either of the forms and intra-
or extracellular Hsp27.
Connections of the abovementioned markers with ex-
tracellular proteolytic enzymes, matrix metalloproteinases
(MMPs) and their tissue inhibitors (TIMPs), have been
known in the case of sFas/sFasL. sFasL is proteolytically
shed from its membrane-bound form by MMPs (Kayagaki
et al. 1995). The strongest evidence for such activity
concerns matrilysin (MMP-7) and has been shown in in
vitro experiments (Vargo-Gogola et al. 2002). It has also
been suggested that other MMPs/TIMPs may control the
sFas/sFasL activity (Musiał and Zwolińska 2011). Noth-
ing is known about possible connections between extra-
cellular Hsp27, MMPs, and TIMPs in chronic kidney
disease patients.
Therefore, our aim was to assess the serum levels of
Hsp27 in relation to sFas and sFasL, in children with chron-
ic kidney disease, in patients on peritoneal dialysis and
hemodialysis, searching for the differences between those
modalities. We also investigated the correlations between
Hsp27, matrix metalloproteinases (MMP-7), their tissue
inhibitors (TIMP-1), markers of inflammation (high sensi-
tivity CRP, IL-4), and endothelial damage (sE-selectin) in
the pediatric population with CKD.
Materials and methods
Sixty-seven CKD patients enrolled in the study were divided
into three groups. The first group (CKD) contained 26 patients
(ten girls, 16 boys) aged 2.0–16.5 years (median, 10.5 years)
with CKD stage 5, yet on conservative treatment (median
glomerular filtration rate (GFR) calculated according to the
Schwartz formula 13 ml/min/1.73 m2) (Schwartz et al. 2009).
Primary diseases causing CKD were reflux nephropathy (13),
chronic glomerulonephritis (nine), neurogenic bladder (three),
hemolytic uremic syndrome (one). In all patients, phosphate
binders and vitamin D metabolites were supplemented.
The second group consisted of 22 children (12 girls, ten
boys) aged 4.0–15.5 years (median, 10.0 years) on automated
peritoneal dialysis (APD, Baxter, Home choice), five of them
having residual renal function. Mean Kt/V value was 1.4. The
patients had five to eight exchanges of dialysis fluid during the
night and, if necessary, one or two during the day. Peritoneal
fluids used in our patients had glucose concentrations of
1.36 % or 2.27 %. The causative factors in CKDwere chronic
pyelonephritis (seven), chronic glomerulonephritis (six), poly-
cystic kidney disease (two), neurogenic bladder (three), he-
molytic uremic syndrome (two), and unknown (two).
The third group included 19 patients (ten girls, nine boys)
aged 10.5–17.0 years (median, 13.5 years), hemodialyzed on
polysulfone membranes, only three out of them with residual
kidney function. Hemodialysis (HD) sessions (3.5–4 h) were
performed three times a week, using bicarbonate dialysate, the
blood flow ranged from 150 to 200 ml/min, dialysate flow did
not exceed 500 ml/min. The membrane area was between 1.0
and 1.6 m2, the dialyzers were not reused. The water, purified
by reosmosis, was regularly checked for contamination. Mean
Kt/V value was 1.3. All patients were on stable anticoagula-
tion regimen using non-fractionated or low-molecular weight
heparin. The causative factors in chronic renal failure were
chronic glomerulonephritis (seven cases), chronic pyelone-
phritis (seven), neurogenic bladder (two), polycystic kidney
disease (one), and unknown (two).
Thirty children (16 girls, 14 boys) aged 5.5–15.5 years
(median, 10.0 years) with primary nocturnal enuresis and
normal kidney function, served as controls.
None of the patients showed clinical evidence of infection,
had diabetes, malignancies or vasculitides, smoked, took anti-
biotics, statins, corticosteroids, or immunosuppressive thera-
py. They were also free of such comorbidities as diabetes,
cardiovascular disease, peripheral vascular disease, or obesity.
In the CKD group, blood pressure was well controlled either
without medication (18 children) or with the use of calcium
channel blockers (five patients) and β-blockers (three chil-
dren). All APD children had their blood pressure values below
the 90th percentile, adjusted for gender and age, according to
the criteria of the fourth report on high blood pressure in
children and adolescents (National 2004) and did not require
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anti-hypertensives. The blood pressure in our HD patients was
within normal values without medication (12 patients) or was
well controlled with the use of calcium channel blockers only
(three) or calcium channel blockers with β-blockers (four).
Informed consent was obtained from the subjects and
their parents, if necessary. The research project has been
approved by the university ethics committee in accordance
with the Helsinki declaration.
Blood samples were drawn after an overnight fast from
peripheral veins in CKD and APD patients and in controls,
in HD subjects twice—from the afferent line of the first-use
dialyzer before starting an HD session and after finishing it.
Samples were clotted for 30 min, centrifuged at 4°C for
10 min, and then serum was stored at −20°C until assayed.
Serum concentrations of Hsp27, sFas, sFasL, MMP-7
(matrilysin), and TIMP-1 were evaluated by commercially
available ELISA kits (Stressgen, R&D Systems, Abingdon,
UK). Standards and serum samples were transferred to 96-
well microplates pre-coated with recombinant antibodies to
human Hsp27, sFas, sFasL, MMP-7, and TIMP-1. Each
sample was tested in duplicate, and the arithmetical mean
was considered a final result. Measurements were performed
according to the manufacturer’s instructions; results were
calculated by reference to standard curves.
In all patients, high sensitivity CRP (nephelometry by
Dade Behring, Marburg, Germany), interleukin (IL)-4 and
sE-selectin (ELISA kits by R&D Systems) as markers of
inflammation/endothelial dysfunction, were also evaluated.
Statistical analysis
Results are expressed as median values and interquartile
ranges. Since the null hypothesis of normality of distribution
was rejected by Shapiro–Wilk test, multiple comparisons
and comparisons in pairs were evaluated by using nonpara-
metric tests (Kruskall–Wallis, Mann–Whitney U, Wil-
coxon). The relations between parameters were assessed
by Spearman’s rank correlation coefficient and by linear
regression analysis. The linear regression equations were
calculated as y 0 βx + a (y, dependent variable; β, regression
coefficient; x, independent variable; a, constant term). We
presented only those equations where both regression coef-
ficient and constant term were statistically significant. Sta-
tistical analysis was performed using the package Statistica
ver. 9.0. A p value<0.05 was considered significant.
Results
Hsp27
Hsp27 median values were significantly increased in CKD
stage 5 children and in all dialyzed patients when compared
to controls (Fig. 1). The concentrations in pre-dialysis sub-
jects were significantly lower than in those on dialysis,
irrespective of the modality. Although a single HD session
decreased the concentrations of Hsp27, they were elevated
vs. those in APD children both before and after a single HD
session (Fig. 1).
sFas, sFasL, MMP-7, and TIMP-1
The median values of sFas, sFasL, MMP-7, and TIMP-1
were increased in the CKD population when compared to
the controls and rose on dialysis, being the highest in
patients on hemodialysis (Figs. 2, 3, 4, 5). A single HD
session diminished the concentrations of sFas, sFasL,
MMP-7, and TIMP-1 to the values lower than those in
APD patients, yet they remained higher than the levels in
CKD patients (Figs. 2, 3, 4, 5).
hsCRP, IL-4, sE-selectin
hsCRP levels did not differ between examined groups. IL-4
concentrations, although increased in all pre-dialysis and
dialyzed children, failed to distinguish between CKD and
different modalities. sE-selectin values rose with dialysis
commencement and were higher in HD subjects than in
the APD ones. However, a single HD session had no impact
on any of the abovementioned parameters.
Linear regression analysis
Since there was no difference in results of regression anal-
ysis between APD and HD patients, we decided to treat
them as a whole in order to get more reliable data from a
bigger group.
Consequently, sFas, sFasL, MMP-7, and TIMP-1 pre-
dicted most accurately (R2≥0.8) the values of Hsp27 in the
group of dialyzed patients (Table 1). Contrarily, in the CKD
population they did not show a sufficiently predictive value.
No significant associations between Hsp27 and inflam-
mation/endothelial dysfunction markers (hsCRP, IL-4, sE-
selectin) were observed. No correlations with selected
parameters of dialysis adequacy, such as Kt/V, hemoglobin,
albumin, urea, calcium, phosphate, or parathormone levels
were noticed either.
Discussion
Our study describes for the first time the disturbed Hsp27
concentrations, and the potential role of sFas/sFasL, MMP-7
and TIMP-1 in their regulation, in children with chronic
kidney disease treated conservatively and on chronic
dialysis.
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Hsp27 serum levels were increased in our pre-dialysis
patients, which is concordant with previous observations in
adults, suggesting the progressive character of those
changes and their dependence on the aggravation of renal
failure (Lebherz-Eichinger et al. 2012). CKD has a multi-
factorial stress background, conditioned by uremic toxicity,
chronic inflammation, and increased oxidative stress. The
progression of kidney disease is also connected with de-
creasing medullary perfusion, and serum Hsp27 has recently
been connected with this parameter (Marquez et al. 2012).
Therefore, all abovementioned factors may account for cell
disintegration and subsequent enhancement of extracellular
Hsp concentrations. Moreover, the effect of Hsp elevation
may be strengthened by the molecule accumulation due to
CKD progression, especially when it is confirmed by an
inverse correlation with eGFR (Lebherz-Eichinger et al.
2012).
Our main interest was focused on the comparison of
children with CKD stage 5, not on dialysis yet, with those
who have already started the renal replacement therapy.
Therefore, we analyzed the patients with comparable eGFR
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Fig. 1 Serum Hsp27



































APD vs. before HD
Fig. 2 Serum sFas
concentrations in the examined
groups
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concomitant with the dialysis commencement. Indeed, fur-
ther Hsp27 elevation, appearing along with the dialysis
initiation and present in the case of both modalities, strongly
suggests that renal replacement therapy per se may create a
stressful condition, aggravating cell damage intensity. That
increase was more evident in patients on hemodialysis than
in those who were dialyzed peritoneally, showing the stron-
ger destructive potential of HD when confronted with APD.
Another explanation for APD–HD discrepancy might be the
difference in adequacy of both methods. Clinical data show
that such criteria as metabolic and anemia control, are better
fulfilled in APD children than in the HD ones. One of the
reasons is the fact that every night exchanges in APD cause
less fluctuations in uremic toxin concentrations than HD
performed only three times a week. It also gives rise to a
suggestion that the increase in hemodialysis frequency
would diminish sinusoidal changes in parameter concentra-
tions, approximating the continuous schedule of nightly
peritoneal dialysis.
When a single HD session was analyzed, the concentra-
tions of Hsp27, sFas, sFasL, MMP-7, and TIMP-1 were




































Fig. 3 Serum sFasL





































APD vs. before HD
Fig. 4 Serum MMP-7 concen-
trations in the examined groups
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probable explanations of post-dialytic decrease, there are
such as adsorption on the dialyzer surface or formation of
various complexes: sFas–sFasL, MMP-7–TIMP-1, or
Hsp27–anti-Hsp27 binding. However, the presence of anti-
Hsp27 antibodies has only been proved in the patients with
coronary syndromes (Shams et al. 2008). Moreover, the
diminished post-dialysis Hsp27 values were still higher than
those in children on peritoneal dialysis. Contrarily, other
markers showed a decreasing tendency in post-dialysis con-
centrations vs. values in APD patients. Therefore, the pat-
tern of Hsp27 behavior during hemodialysis session differs
from that characteristic for sFas/sFasL, MMP-7, or TIMP-1.
Since molecular masses of analyzed molecules are not large-
ly discrepant (27–50 kDa), the difference in filtration is
rather negligible. Thus, the release of extracellular Hsp27
due to the contact of cells with the dialyzer membrane, not
compensated by the molecule elimination, seems possible.
Such discrepancy in favor of APD seems of paramount
significance in children because in this population peritoneal
dialysis is a method of choice. The only available compar-
ative data concerning Hsp27 in dialyzed subjects come from





























APD vs. before HD
p < 0.01




Fig. 5 Serum TIMP-1 concen-
trations in the examined groups
Table 1 The linear regression analysis of assessed parameters in CKD children and in all patients on dialysis (APD + HD)
Dependent variable Independent variable Regression coefficient β Constant term Coefficient of determination R2 p
CKD patients
Hsp27 [ng/ml] sFas [pg/ml] 0.003 39.67 0.29 0.03
sFasL [pg/ml] 0.38 31.12 0.36 0.007
MMP-7 [ng/ml] 2.12 49.41 0.009 0.28
TIMP-1 [ng/ml] 0.08 45.56 0.12 0.08
hsCRP [mg/l] −1.77 56.47 0.13 0.06
IL-4 [pg/ml] −0.02 56.14 0.002 0.81
sE-selectin [pg/ml] 0.08 49.84 0.11 0.09
APD + HD patients
Hsp27 [ng/ml] sFas [pg/ml] 0.01 −24.17 0.80 0.002
sFasL [pg/ml] 0.62 31.47 0.89 0.000001
MMP-7 [ng/ml] 50.05 −122.58 0.84 0.000001
TIMP-1 [ng/ml] 0.11 70. 47 0.89 0.000001
hsCRP [mg/l] 0.21 97.58 0.01 0.48
IL-4 [pg/ml] 0.34 84.58 0.06 0.42
sE-selectin [pg/ml] 0.06 93.59 0.004 0.69
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and carotid intima-media thickness was noticed in adults on
hemodialysis (Mohammadpour et al. 2011). However, there
was no reference control group, so the potential serum
Hsp27 increases in chronically dialyzed patients could not
be proven. The patients on peritoneal dialysis were not taken
into account either. Therefore, to the best of our knowledge,
this study is the first analyzing serum Hsp27 both in hemo-
dialysis and peritoneal dialysis patients, in comparison with
pre-dialysis CKD subjects and control group.
The interesting finding was the correlations between
Hsp27 and its potential regulators, strengthened by the
results of linear regression analysis. All examined parame-
ters (MMP-7, TIMP-1, sFas, sFasL) predicted Hsp27 con-
centrations in pediatric patients on dialysis. Moreover, our
previous investigation has revealed that MMPs and TIMPs
may well predict sFas/sFasL in dialyzed children (Musiał
and Zwolińska 2011). MMP-7 engagement in sFasL regu-
lation has also been proven by others and seems probable
for sFas too (Vargo-Gogola et al. 2002; Musiał and
Zwolińska 2011; Williams et al. 2010). Additionally,
TIMP-1 anti-apoptotic activity, independent of its inhibitory
action towards MMPs, has been described recently (Guo et
al. 2006). The role of sFas/sFasL system in apoptosis regu-
lation was analyzed within the aspect of dialysis as well
(Musiał and Zwolińska 2011).
All together, these connections strongly suggest the en-
gagement of evaluated parameters in tissue homeostasis and
regeneration following the cell damage. In the case of
MMPs and TIMPs, such activity results from their function-
ing as proteolytic enzymes, degrading and remodeling the
matrix components. The sFas/sFasL impact on apoptosis is
also the tool for controlling tissue destruction and restora-
tion. Thus, the fact that MMPs, TIMPs, sFas, and sFasL are
Hsp27 predictors in dialyzed patients, suggests the potential
role of Hsp27 as a marker of cell damage seen in patients
with chronic kidney disease.
However, some differences require careful attention.
Both MMP-7 and TIMP-1 turned out to be useful predictors
of Hsp27 concentrations in patients on dialysis, whereas no
such link was observed in the case of pre-dialysis children
with CKD stage 5. The same results concerned sFas and
sFasL—they predicted very accurately Hsp27 concentra-
tions in dialyzed subjects, but were ineffective as predictors
of Hsp27 in the population of pre-dialysis CKD children.
Such discrepancy may mean that factors triggering Hsp27
increase vary between those populations and uremic toxicity
plays a paramount role in pre-dialysis patients, whereas in
subjects on dialysis the therapy itself, with its bio-
incompatibility and inadequacy above all, is able to trigger
and aggravate dialysis-related stress reactions. Together
with the discrepancies between HD and APD, favoring the
latter, Hsp27 serum levels create a new quality in assessing
biocompatibility of dialysis modalities. Surely, this theory
needs to be verified in the course of future investigation
performed on a bigger group of patients.
Finally, the hypothetical chain of reactions can be built,
starting with Hsp27 overexpression due to stress conditions
characteristic for chronic kidney disease. The next step
would be the stimulation of pro-inflammatory cytokines
and NF-κB (Parcellier et al. 2003), triggering MMP and
TIMP overactivity that in turn determines sFas/sFasL re-
lease. The latter would control the intensity of apoptosis,
thus influencing the process of tissue damage followed by
restoration. Consequently, the amount of extracellular
Hsp27 that is released could serve as an easily accessible
universal marker of a degree of cell damage due to CKD-
related confounders such as uremic toxicity or bio-
incompatibility of materials used for dialysis procedures.
Of note, its additional value can be derived from the fact
that it is independent of potential cofactors influencing
CKD, such as inflammation or endothelial damage. In this
respect, all results of regression analysis would be the proof
of serum Hsp27 applicability in assessing the degree of cell
damage resulting from bio-incompatibility in children on
chronic dialysis.
Conclusions
Children with chronic kidney disease are prone to Hsp27
dysfunction, aggravated by the dialysis commencement and
more pronounced in patients on hemodialysis. Correlations
between Hsp27 and examined parameters suggest the po-
tential role for Hsp27 as a marker of bio-incompatibility-
related cell damage in the pediatric population on chronic
dialysis.
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